Francesco Spagnolo

9PUBLICATIONS
110CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycologyMolecular targetsReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Mar 07, 2024
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study.

Jason J Luke, Paolo A Ascierto, Muhammad A Khattak

|Feb 24, 2024
Primary endobronchial melanoma: a case report and clinical management indications.

Emanuela Barisione, Andrea Boutros, Marco Mora

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Feb 27, 2022
Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis.

L Arecco, E Blondeaux, M Bruzzone

|May 22, 2021
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review.

Francesco Spagnolo, Andrea Boutros, Elena Croce

Pageof 2

Frequent Collaborators

3 joint publications

Paolo A Ascierto

2 joint publications

Piotr Rutkowski

2 joint publications

Andrea Boutros

2 joint publications

Marco Tucci